Entero Therapeutics Inc (ENTO)
1.76
-0.01
(-0.65%)
USD |
NASDAQ |
Jun 25, 16:00
1.73
-0.03
(-1.70%)
After-Hours: 20:00
Entero Therapeutics Free Cash Flow: -13.28M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -13.28M |
| December 31, 2023 | -12.38M |
| September 30, 2023 | -14.53M |
| June 30, 2023 | -15.45M |
| March 31, 2023 | -17.28M |
| December 31, 2022 | -22.34M |
| September 30, 2022 | -22.61M |
| June 30, 2022 | -34.09M |
| March 31, 2022 | -35.13M |
| December 31, 2021 | -42.61M |
| September 30, 2021 | -32.39M |
| June 30, 2021 | -19.36M |
| March 31, 2021 | -15.00M |
| December 31, 2020 | -11.23M |
| September 30, 2020 | -8.567M |
| June 30, 2020 | -10.03M |
| March 31, 2020 | -12.71M |
| Date | Value |
|---|---|
| December 31, 2019 | -14.06M |
| September 30, 2019 | -14.17M |
| June 30, 2019 | -12.69M |
| March 31, 2019 | -11.32M |
| December 31, 2018 | -10.92M |
| September 30, 2018 | -10.05M |
| June 30, 2018 | -8.676M |
| March 31, 2018 | -8.295M |
| December 31, 2017 | -7.217M |
| September 30, 2017 | -6.764M |
| June 30, 2017 | -6.687M |
| March 31, 2017 | -5.076M |
| December 31, 2016 | -4.547M |
| September 30, 2016 | -3.253M |
| June 30, 2016 | -3.779M |
| March 31, 2016 | -3.795M |
| December 31, 2015 | -4.195M |
Free Cash Flow Range, Past 5 Years
-42.61M
Minimum
Dec 2021
-8.567M
Maximum
Sep 2020
-19.00M
Average
-14.77M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.747M |
| Cash from Investing (Quarterly) | 0.0882M |
| Cash from Financing (Quarterly) | 3.379M |
| Free Cash Flow Per Share (Quarterly) | -0.2582 |
| Free Cash Flow Yield | -182.2% |